{"id":"NCT00988208","sponsor":"Celgene","briefTitle":"Study to Evaluate Safety and Effectiveness of Lenalidomide in Combination With Docetaxel and Prednisone for Patients With Castrate-Resistant Prostate Cancer","officialTitle":"A Phase 3 Study to Evaluate the Efficacy and Safety of Docetaxel and Prednisone With or Without Lenalidomide in Subjects With Castrate-Resistant Prostate Cancer (CRPC)","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2009-11-11","primaryCompletion":"2012-01-13","completion":"2016-11-28","firstPosted":"2009-10-02","resultsPosted":"2013-09-05","lastUpdate":"2018-04-04"},"enrollment":1059,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Prostate Cancer"],"interventions":[{"type":"DRUG","name":"Lenalidomide","otherNames":["CC-5013","Revlimid"]},{"type":"DRUG","name":"Docetaxel","otherNames":["Taxotere"]},{"type":"DRUG","name":"Prednisone","otherNames":["There are multiple brand names for prednisone."]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Docetaxel, Prednisone, Lenalidomide (DPL)","type":"EXPERIMENTAL"},{"label":"Docetaxel and Prednisone (DP)","type":"EXPERIMENTAL"}],"summary":"The purpose of the study is to determine whether lenalidomide is safe and effective for use in combination with docetaxel and prednisone for the treatment of subjects with metastatic Castrate-Resistant Prostate Cancer.\n\nThe addition of lenalidomide to docetaxel and prednisone is proposed to increase the life expectancy of these subjects.","primaryOutcome":{"measure":"Overall Survival (OS)","timeFrame":"From randomization until death from any cause up to the cut-off date of 13 January 2012; up to approximately 26 months","effectByArm":[{"arm":"Docetaxel/Prednisone/Placebo (DP)","deltaMin":null,"sd":null},{"arm":"Docetaxel/Prednisone/Lenalidomide (DPL)","deltaMin":77,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0017"}]},"eligibility":{"minAge":"18 Years","sex":"MALE","healthyVolunteers":false,"inclusionCount":null,"exclusionCount":null},"locations":{"siteCount":210,"countries":["United States","Australia","Austria","Belgium","Canada","Czechia","Denmark","France","Germany","Greece","Hungary","Israel","Italy","Mexico","Netherlands","Poland","Russia","South Africa","Spain","Sweden","United Kingdom"]},"refs":{"pmids":["27522164","25743937","27560549"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":283,"n":525},"commonTop":["FATIGUE","ALOPECIA","DIARRHOEA","NAUSEA","OEDEMA PERIPHERAL"]}}